Oxygenta Pharmaceutical Ltd Closes Trading Window Until 48 Hours After Q4 Results in 2026

Oxygenta Pharmaceutical Limited (Scrip Code: 524636) has announced the closure of its trading window for dealing in the securities of the company. The closure will be in effect from 01.04.2026 till 48 hours after the declaration of audited Financial Results for the quarter and year ending 31.03.2026. This decision is in accordance with the Company’s Code of Conduct for Prevention of Insider Trading adopted under SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure applies to all designated persons, their immediate relatives, and all connected persons covered under the Company’s Code of Conduct. The Board Meeting is scheduled to consider and approve the audited Financial Results for the quarter and year ending 31.03.2026. An intimation regarding the notice of the Board Meeting will be sent separately to the Stock Exchange.